Oxandrin and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Oxandrin (oxandrolone).
High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Major Potential Hazard, Moderate plausibility
androgens - hyperlipoproteinemia
Androgenic anabolic steroids may adversely affect serum lipids, including lowering HDL and elevating LDL levels. These changes can be marked, particularly with the 17-alpha-alkyl derivatives (i.e., fluoxymesterone, methyltestosterone, oxandrolone, oxymetholone, and stanozolol), and may significantly impact the risk of atherosclerosis and coronary artery disease. Patients with preexisting hyperlipoproteinemia may require closer monitoring during therapy with androgenic agents, and adjustments made accordingly in their lipid-lowering regimen. Androgen therapy should be administered cautiously in patients with coronary artery disease or a history of ischemic heart disease.
References
- "Product Information. Halotestin (fluoxymesterone)." Pharmacia and Upjohn PROD (2001):
- "Product Information. Androderm (testosterone topical)." SmithKline Beecham PROD (2001):
Oxandrin drug interactions
There are 93 drug interactions with Oxandrin (oxandrolone).
Oxandrin disease interactions
There are 10 disease interactions with Oxandrin (oxandrolone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- diabetes
- hypercalcemia
- thyroid function tests
More about Oxandrin (oxandrolone)
- Oxandrin consumer information
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.